Pralatrexate 65219-0550

Product NDC

65219-0550

Manufacturer: Fresenius Kabi Usa, Llc
Dosage Form: Injection
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: November 15, 2022
Listing Expires: December 31, 2026
Application: NDA022468

Need to source Pralatrexate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Pralatrexate	20 mg/mL

Drug Class

Folate Analog Metabolic Inhibitor [EPC]Folate Analog Metabolic Inhibitor [EPC]

Packaging Options(1)

65219-0550-01

1 VIAL, SINGLE-DOSE in 1 CARTON (65219-550-01) / 1 mL in 1 VIAL, SINGLE-DOSE

View →